FORBES-TATE for MERCK
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to Part D Medicare, the drug industry, vaccines, PCORI, ASP+6 and 340B; issues related to the Prescription Drug User Fee Act; issues related to pharmaceutical drug safety track and trace program legislation; issues related to comparative effectiveness, issues related to the Independent Payment Advisory Board; Issues relating to trade negotiations; PNTR with Russia; Issues related to international tax, check the box, and tax deferral; issues related to the R&D tax credit and corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES New | Staff Director, Senate Finance Committee ; ; Chief of Staff, Senator Max Baucus ; ; Deputy Asst, Special Asst, Deputy Director EOP |
| ELIZABETH GREER New | Chief of Staff, Rep. Allen Boyd |
Pharmacy PHA
Issues related to Part D Medicare, the drug industry, vaccines, PCORI, ASP+6 and 340B; issues related to the Prescription Drug User Fee Act; issues related to pharmaceutical drug safety track and trace program legislation; issues related to comparative effectiveness, issues related to the Independent Payment Advisory Board; Issues relating to trade negotiations; PNTR with Russia; Issues related to international tax, check the box, and tax deferral; issues related to the R&D tax credit and corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES New | Staff Director, Senate Finance Committee ; ; Chief of Staff, Senator Max Baucus ; ; Deputy Asst, Special Asst, Deputy Director EOP |
| ELIZABETH GREER New | Chief of Staff, Rep. Allen Boyd |
Trade (domestic/foreign) TRD
Issues related to Part D Medicare, the drug industry, vaccines, PCORI, ASP+6 and 340B; issues related to the Prescription Drug User Fee Act; issues related to pharmaceutical drug safety track and trace program legislation; issues related to comparative effectiveness, issues related to the Independent Payment Advisory Board; Issues relating to trade negotiations; PNTR with Russia; Issues related to international tax, check the box, and tax deferral; issues related to the R&D tax credit and corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES New | Staff Director, Senate Finance Committee ; ; Chief of Staff, Senator Max Baucus ; ; Deputy Asst, Special Asst, Deputy Director EOP |
| ELIZABETH GREER New | Chief of Staff, Rep. Allen Boyd |
Health Issues HCR
Issues related to Part D Medicare, the drug industry, vaccines, PCORI, ASP+6 and 340B; issues related to the Prescription Drug User Fee Act; issues related to pharmaceutical drug safety track and trace program legislation; issues related to comparative effectiveness, issues related to the Independent Payment Advisory Board; Issues relating to trade negotiations; PNTR with Russia; Issues related to international tax, check the box, and tax deferral; issues related to the R&D tax credit and corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES New | Staff Director, Senate Finance Committee ; ; Chief of Staff, Senator Max Baucus ; ; Deputy Asst, Special Asst, Deputy Director EOP |
| ELIZABETH GREER New | Chief of Staff, Rep. Allen Boyd |
Medicare/Medicaid MMM
Issues related to Part D Medicare, the drug industry, vaccines, PCORI, ASP+6 and 340B; issues related to the Prescription Drug User Fee Act; issues related to pharmaceutical drug safety track and trace program legislation; issues related to comparative effectiveness, issues related to the Independent Payment Advisory Board; Issues relating to trade negotiations; PNTR with Russia; Issues related to international tax, check the box, and tax deferral; issues related to the R&D tax credit and corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES New | Staff Director, Senate Finance Committee ; ; Chief of Staff, Senator Max Baucus ; ; Deputy Asst, Special Asst, Deputy Director EOP |
| ELIZABETH GREER New | Chief of Staff, Rep. Allen Boyd |
Budget/Appropriations BUD
Issues related to Part D Medicare, the drug industry, vaccines, PCORI, ASP+6 and 340B; issues related to the Prescription Drug User Fee Act; issues related to pharmaceutical drug safety track and trace program legislation; issues related to comparative effectiveness, issues related to the Independent Payment Advisory Board; Issues relating to trade negotiations; PNTR with Russia; Issues related to international tax, check the box, and tax deferral; issues related to the R&D tax credit and corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FORBES New | Staff Director, Senate Finance Committee ; ; Chief of Staff, Senator Max Baucus ; ; Deputy Asst, Special Asst, Deputy Director EOP |
| ELIZABETH GREER New | Chief of Staff, Rep. Allen Boyd |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.